Clinical Outcomes of Endoscopic Submucosal Dissection for Early Gastric Cancer in Different Indications

Clinical Outcomes of Endoscopic Submucosal Dissection for Early Gastric Cancer in Different Indications

Author Info

Corresponding Author
Ruihua Shi
Department of Gastroenterology, Southeast University Affiliated Zhongda Hospital, Nanjing, China

A B S T R A C T

Gastric cancer still threatens the health of people, which is the fifth most common cancer and the fourth leading cancer-related death worldwide. The stage of the disease is critical for the 5-year survival of gastric cancer; the 5-year survival rates could reach 90% for gastric cancer detected at early stages. At present, endoscopic submucosal dissection (ESD) is the main treatment for early gastric cancer. Referring to the treatment guideline of the Japan Gastric Cancer Association, the indications for ESD mainly include absolute indications, expanded indications, and relative indications. Many studies have reported favourable long-term outcomes after undergoing ESD, and compared with surgery, ESD preserves the entire stomach and improves the quality of life of patients. However, it has also been reported that the recurrence rate of gastric cancer after ESD is high, so regular follow-up and careful examination are needed, even for patients with early gastric cancer who met absolute indications.

Article Info

Article Type
Review Article
Publication history
Received: Tue 11, Jan 2022
Accepted: Wed 26, Jan 2022
Published: Wed 09, Feb 2022
Copyright
© 2021 Ruihua Shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.COR.2022.01.03